Todd Shegog - 05 Jun 2024 Form 4 Insider Report for Cogent Biosciences, Inc. (COGT)

Role
Director
Signature
/s/ Evan D. Kearns, Attorney-in-Fact
Issuer symbol
COGT
Transactions as of
05 Jun 2024
Net transactions value
$0
Form type
4
Filing time
13 Jun 2024, 19:07:34 UTC
Previous filing
08 Jun 2023
Next filing
05 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COGT Stock Option (Right to Buy) Award $0 +44,700 $0.000000 44,700 05 Jun 2024 Common Stock 44,700 $8.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2025 Annual Meeting of Stockholders.